Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-12-04, Stock:NVS, The news for the past five days is as follows:
2019-11-26: NEWS1: This Biotech Broke Out Bullishly — But Couldn't Hold Onto That Gain.NEWS2: A new Sickle cell disease drug holds much promise but most sufferers won’t be able to afford it.NEWS3: A new Sickle cell disease drug holds much promise but most sufferers won’t be able to afford it.NEWS4: Global Blood Therapeutics stock is up on sickle cell therapy approval.NEWS5: Novartis Securities Investment Ltd -- Moody's affirms Novartis' A1 rating; stable outlook.NEWS6: 4 Big Drug Stocks Ripe for Takeover After NVS-MDCO Deal.NEWS7: Top 5 Things to Know in the Market on Tuesday.
2019-11-27: NEWS1: FOCUS-Pfizer, Novartis lead $2 bln spending spree on gene therapy production.NEWS2: Pfizer, Novartis lead $2 billion spending spree on gene therapy production.NEWS3: FOCUS-Pfizer, Novartis lead pharma spending spree on gene therapy production.NEWS4: Global Blood's (GBT) Oxbryta Secures FDA Approval for SCD.NEWS5: Why Biotech ETFs Surged in Monday's Trading Session.
2019-11-29: nan
2019-12-02: NEWS1: Intercept (ICPT) Gains 7.5% YTD on Progress in NASH Space.NEWS2: Novartis-linked biotech firm raises $56M for new spinouts.
2019-12-03: NEWS1: Biogen's Shares Down on Rating Downgrade by Baird Analyst.NEWS2: Where to Buy Booming Biotech ETFs.NEWS3: Gene-Therapy Firm Audentes Sold for Double Its Share Price. Analysts Expect More Deals..NEWS4: Astellas bets $3 billion in gene therapy deal.

Answer: Rise